Exicure Inc (XCUR)

US · Healthcare · Biotechnology

$1.35+1.50%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.1M

EPS

$-0.18

Market cap

$9.0M

Forward P/E

0.0

P/B

9.18

Book value

$0.33

EPS (TTM)

$-1.31

52-week high

$9.48

52-week low

$1.05

50-day MA

$1.52

200-day MA

$3.50

Beta

3.62

Analysts rate Exicure Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $2.00.

Insiders

41.47%

Institutions

2.25%

Fund	Stake
Geode Capital Management, LLC	0.56%
Vanguard Capital Management, LLC	0.50%
Citadel Advisors Llc	0.23%
Vanguard Fiduciary Trust Co	0.20%
Northern Trust Corp	0.16%
BlackRock Inc	0.14%
UBS Group AG	0.01%
Tower Research Capital LLC	0.01%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Exicure Inc — free to start.

Data updated 2026-09-18.